Table 1.
All (n=31) | Histological Remission (<15 eos/hpf) (n=18) | Non-responders (≥15 eos/hpf) (nv13) |
P | |
---|---|---|---|---|
Gender (% males) | 26 (84%) | 16 (89%) | 10 (77%) | 0.4 |
Food allergy (%) | 10 (32%) | 4 (22%) | 6 (46%) | 0.2 |
Age (years) | 9 (IQR=7,13) | 9 (IQR=14,7) | 8 (IQR=5,9) | 0.2 |
Age at diagnosis (years) | 6 (IQR=3,9) | 6 (IQR=3,9) | 5 (IQR=3,8) | 0.7 |
Treatment duration (months) | 3 (IQR=3,4) | 3 (IQR=3,3) | 3 (IQR=3,4) | 0.3 |
Pre-tx (eos/hpf) | 37 (IQR=28,61) | 38 (IQR=26,59) | 37 (IQR=28,63) | 0.7 |
Post-tx (eos/hpf) | 7.2 (IQR=2,33) | 2 (IQR=0,6) | 37 (IQR=29,57) | < .00001 |